Zydus Lifesciences Limited has informed the Exchange about Buyback
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences Limited has submitted its Letter of Offer for a buyback of up to 87,30,158 equity shares (0.87% of paid-up capital) at INR 1,260 per share, aggregating to INR 1,100 crore. The buyback is through the tender offer route via NSE (designated stock exchange). Small shareholders (holding shares worth up to INR 2 lakh as on record date) receive preferential treatment with 10.20% entitlement ratio compared to 0.75% for general category shareholders. The buyback opens on June 4, 2026 and closes on June 10, 2026, with settlement on June 17, 2026. The buyback size represents 5.16% and 3.84% of standalone and consolidated free reserves respectively, within the statutory 10% limit.
The buyback offers a price of INR 1,260 per share, representing a 9.6% increase from the originally approved price of INR 1,150, signaling management confidence in the company's valuation. Shareholders participating will receive cash for tendered shares at this price.